264 related articles for article (PubMed ID: 9560198)
1. Mechanism of platelet inhibition by nitric oxide: in vivo phosphorylation of thromboxane receptor by cyclic GMP-dependent protein kinase.
Wang GR; Zhu Y; Halushka PV; Lincoln TM; Mendelsohn ME
Proc Natl Acad Sci U S A; 1998 Apr; 95(9):4888-93. PubMed ID: 9560198
[TBL] [Abstract][Full Text] [Related]
2. Thromboxane-insensitive dog platelets have impaired activation of phospholipase C due to receptor-linked G protein dysfunction.
Johnson GJ; Leis LA; Dunlop PC
J Clin Invest; 1993 Nov; 92(5):2469-79. PubMed ID: 8227362
[TBL] [Abstract][Full Text] [Related]
3. Thromboxane A2-mediated shape change: independent of Gq-phospholipase C--Ca2+ pathway in rabbit platelets.
Ohkubo S; Nakahata N; Ohizumi Y
Br J Pharmacol; 1996 Mar; 117(6):1095-104. PubMed ID: 8882602
[TBL] [Abstract][Full Text] [Related]
4. Identification of Galpha13 as one of the G-proteins that couple to human platelet thromboxane A2 receptors.
Djellas Y; Manganello JM; Antonakis K; Le Breton GC
J Biol Chem; 1999 May; 274(20):14325-30. PubMed ID: 10318854
[TBL] [Abstract][Full Text] [Related]
5. Von Willebrand factor activates endothelial nitric oxide synthase in blood platelets by a glycoprotein Ib-dependent mechanism.
Riba R; Oberprieler NG; Roberts W; Naseem KM
J Thromb Haemost; 2006 Dec; 4(12):2636-44. PubMed ID: 17100655
[TBL] [Abstract][Full Text] [Related]
6. Activation of G12/G13 results in shape change and Rho/Rho-kinase-mediated myosin light chain phosphorylation in mouse platelets.
Klages B; Brandt U; Simon MI; Schultz G; Offermanns S
J Cell Biol; 1999 Feb; 144(4):745-54. PubMed ID: 10037795
[TBL] [Abstract][Full Text] [Related]
7. Antiplatelet effects of caffeic acid due to Ca(2＋) mobilizationinhibition via cAMP-dependent inositol-1, 4, 5-trisphosphate receptor phosphorylation.
Lee DH; Kim HH; Cho HJ; Bae JS; Yu YB; Park HJ
J Atheroscler Thromb; 2014; 21(1):23-37. PubMed ID: 24088646
[TBL] [Abstract][Full Text] [Related]
8. Pathogenesis of a bleeding disorder characterized by platelet unresponsiveness to thromboxane A2.
Fuse I; Higuchi W; Aizawa Y
Semin Thromb Hemost; 2000; 26(1):43-5. PubMed ID: 10805281
[TBL] [Abstract][Full Text] [Related]
9. Agonist-induced phosphorylation of human platelet TXA2/PGH2 receptors.
Okwu AK; Mais DE; Halushka PV
Biochim Biophys Acta; 1994 Mar; 1221(1):83-8. PubMed ID: 8130280
[TBL] [Abstract][Full Text] [Related]
10. A platelet secretion pathway mediated by cGMP-dependent protein kinase.
Li Z; Zhang G; Marjanovic JA; Ruan C; Du X
J Biol Chem; 2004 Oct; 279(41):42469-75. PubMed ID: 15280395
[TBL] [Abstract][Full Text] [Related]
11. Identification of Gq as one of the G-proteins which copurify with human platelet thromboxane A2/prostaglandin H2 receptors.
Knezevic I; Borg C; Le Breton GC
J Biol Chem; 1993 Dec; 268(34):26011-7. PubMed ID: 8245033
[TBL] [Abstract][Full Text] [Related]
12. Impaired signal transduction in neonatal platelets.
Israels SJ; Cheang T; Roberston C; McMillan-Ward EM; McNicol A
Pediatr Res; 1999 May; 45(5 Pt 1):687-91. PubMed ID: 10231866
[TBL] [Abstract][Full Text] [Related]
13. Regulation of thromboxane receptor activation in human platelets.
Murray R; FitzGerald GA
Proc Natl Acad Sci U S A; 1989 Jan; 86(1):124-8. PubMed ID: 2521385
[TBL] [Abstract][Full Text] [Related]
14. Homologous desensitization of signalling by the alpha (alpha) isoform of the human thromboxane A2 receptor: a specific role for nitric oxide signalling.
Kelley-Hickie LP; O'Keeffe MB; Reid HM; Kinsella BT
Biochim Biophys Acta; 2007 Jun; 1773(6):970-89. PubMed ID: 17466390
[TBL] [Abstract][Full Text] [Related]
15. Thromboxane A2-induced bi-directional regulation of cerebral arterial tone.
Neppl RL; Lubomirov LT; Momotani K; Pfitzer G; Eto M; Somlyo AV
J Biol Chem; 2009 Mar; 284(10):6348-60. PubMed ID: 19095646
[TBL] [Abstract][Full Text] [Related]
16. Epinephrine correction of impaired platelet thromboxane receptor signaling.
Dunlop PC; Leis LA; Johnson GJ
Am J Physiol Cell Physiol; 2000 Dec; 279(6):C1760-71. PubMed ID: 11078690
[TBL] [Abstract][Full Text] [Related]
17. Defective signal transduction through the thromboxane A2 receptor in a patient with a mild bleeding disorder: deficiency of the inositol 1,4,5-triphosphate formation despite normal G-protein activation.
Mitsui T; Yokoyama S; Shimizu Y; Katsuura M; Akiba K; Hayasaka K
Thromb Haemost; 1997 May; 77(5):991-5. PubMed ID: 9184416
[TBL] [Abstract][Full Text] [Related]
18. Defective signal transduction induced by thromboxane A2 in a patient with a mild bleeding disorder: impaired phospholipase C activation despite normal phospholipase A2 activation.
Fuse I; Mito M; Hattori A; Higuchi W; Shibata A; Ushikubi F; Okuma M; Yahata K
Blood; 1993 Feb; 81(4):994-1000. PubMed ID: 8428006
[TBL] [Abstract][Full Text] [Related]
19. Timosaponin AIII induces antiplatelet and antithrombotic activity via Gq-mediated signaling by the thromboxane A2 receptor.
Cong Y; Wang L; Peng R; Zhao Y; Bai F; Yang C; Liu X; Wang D; Ma B; Cong Y
Sci Rep; 2016 Dec; 6():38757. PubMed ID: 27934923
[TBL] [Abstract][Full Text] [Related]
20. Interaction of nitric oxide and cGMP with signal transduction in activated platelets.
Nguyen BL; Saitoh M; Ware JA
Am J Physiol; 1991 Oct; 261(4 Pt 2):H1043-52. PubMed ID: 1656783
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
